- Home
- HAFN vs VCYT Comparison
HAFN vs VCYT Comparison
Compare HAFN & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HAFN | VCYT |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | HAFN | VCYT |
|---|---|---|
| Price | $6.67 | $32.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $45.13 |
| AVG Volume (30 Days) | ★ 1.8M | 794.2K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 8.21% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | N/A | $12.53 |
| P/E Ratio | ★ $11.39 | $37.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.61 | $22.61 |
| 52 Week High | $7.96 | $50.71 |
Technical Indicators
Market Signals| Indicator | HAFN | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 39.69 | 36.04 |
| Support Level | $6.01 | $25.95 |
| Resistance Level | $7.96 | $32.79 |
| Average True Range (ATR) | 0.24 | 1.47 |
| MACD | -0.15 | -0.28 |
| Stochastic Oscillator | 8.36 | 15.82 |
Price Performance
Historical ComparisonAbout HAFN Hafnia Limited
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.